The store will not work correctly when cookies are disabled.
(1-benzyl-1H-1,2,3-triazol-4-yl)methyl cinnamate
ID: ALA4464197
PubChem CID: 102443145
Max Phase: Preclinical
Molecular Formula: C19H17N3O2
Molecular Weight: 319.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(/C=C/c1ccccc1)OCc1cn(Cc2ccccc2)nn1
Standard InChI: InChI=1S/C19H17N3O2/c23-19(12-11-16-7-3-1-4-8-16)24-15-18-14-22(21-20-18)13-17-9-5-2-6-10-17/h1-12,14H,13,15H2/b12-11+
Standard InChI Key: CQERHGMJGKSYGA-VAWYXSNFSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
14.7823 -9.0964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7812 -9.9159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4892 -10.3249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1989 -9.9154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1960 -9.0928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4874 -8.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9022 -8.6815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6115 -9.0874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3176 -8.6762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0269 -9.0821 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7330 -8.6708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4423 -9.0768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3145 -7.8590 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.5318 -9.8889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3318 -10.0558 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7378 -9.3465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1886 -8.7414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.6670 -10.8011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4800 -10.8834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8124 -11.6267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6246 -11.7093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1033 -11.0460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7640 -10.2979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9528 -10.2189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
9 13 2 0
12 14 2 0
14 15 1 0
15 16 1 0
16 17 2 0
17 12 1 0
15 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 319.36 | Molecular Weight (Monoisotopic): 319.1321 | AlogP: 3.08 | #Rotatable Bonds: 6 |
Polar Surface Area: 57.01 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.09 | CX LogD: 4.09 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.52 | Np Likeness Score: -1.07 |
References
1. Rodrigues MP, Tomaz DC, Ângelo de Souza L, Onofre TS, Aquiles de Menezes W, Almeida-Silva J, Suarez-Fontes AM, Rogéria de Almeida M, Manoel da Silva A, Bressan GC, Vannier-Santos MA, Rangel Fietto JL, Teixeira RR.. (2019) Synthesis of cinnamic acid derivatives and leishmanicidal activity against Leishmania braziliensis., 183 [PMID:31542714] [10.1016/j.ejmech.2019.111688] |